Titre : Lipoprotéines HDL

Lipoprotéines HDL : Questions médicales fréquentes

Termes MeSH sélectionnés :

RNA, Long Noncoding
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lipoprotéines HDL : Questions médicales les plus fréquentes", "headline": "Lipoprotéines HDL : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lipoprotéines HDL : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-02", "dateModified": "2025-03-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lipoprotéines HDL" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lipoprotéines", "url": "https://questionsmedicales.fr/mesh/D008074", "about": { "@type": "MedicalCondition", "name": "Lipoprotéines", "code": { "@type": "MedicalCode", "code": "D008074", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.521" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cholestérol HDL", "alternateName": "Cholesterol, HDL", "url": "https://questionsmedicales.fr/mesh/D008076", "about": { "@type": "MedicalCondition", "name": "Cholestérol HDL", "code": { "@type": "MedicalCode", "code": "D008076", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.521.479.470" } } }, { "@type": "MedicalWebPage", "name": "Pré-bêta-lipoprotéines de haute densité", "alternateName": "High-Density Lipoproteins, Pre-beta", "url": "https://questionsmedicales.fr/mesh/D053442", "about": { "@type": "MedicalCondition", "name": "Pré-bêta-lipoprotéines de haute densité", "code": { "@type": "MedicalCode", "code": "D053442", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.521.479.602" } } }, { "@type": "MedicalWebPage", "name": "Lipoprotéines HDL2", "alternateName": "Lipoproteins, HDL2", "url": "https://questionsmedicales.fr/mesh/D053439", "about": { "@type": "MedicalCondition", "name": "Lipoprotéines HDL2", "code": { "@type": "MedicalCode", "code": "D053439", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.521.479.735" } } }, { "@type": "MedicalWebPage", "name": "Lipoprotéines HDL3", "alternateName": "Lipoproteins, HDL3", "url": "https://questionsmedicales.fr/mesh/D053440", "about": { "@type": "MedicalCondition", "name": "Lipoprotéines HDL3", "code": { "@type": "MedicalCode", "code": "D053440", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.521.479.867" } } } ], "about": { "@type": "MedicalCondition", "name": "Lipoprotéines HDL", "alternateName": "Lipoproteins, HDL", "code": { "@type": "MedicalCode", "code": "D008075", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kyung-Hyun Cho", "url": "https://questionsmedicales.fr/author/Kyung-Hyun%20Cho", "affiliation": { "@type": "Organization", "name": "LipoLab, Yeungnam University, Gyeongsan 38541, Korea." } }, { "@type": "Person", "name": "Anatol Kontush", "url": "https://questionsmedicales.fr/author/Anatol%20Kontush", "affiliation": { "@type": "Organization", "name": "Unité de Recherche sur les Maladies Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM), le Métabolisme et la Nutrition, ICAN, Sorbonne Université, F-75013 Paris, France." } }, { "@type": "Person", "name": "Fernando Brites", "url": "https://questionsmedicales.fr/author/Fernando%20Brites", "affiliation": { "@type": "Organization", "name": "Laboratory of Lipids and Atherosclerosis, Department of Clinical Biochemistry, INFIBIOC, University of Buenos Aires, CONICET. Buenos Aires, Argentina." } }, { "@type": "Person", "name": "Wilfried Le Goff", "url": "https://questionsmedicales.fr/author/Wilfried%20Le%20Goff", "affiliation": { "@type": "Organization", "name": "Unité de Recherche sur les Maladies Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM), le Métabolisme et la Nutrition, ICAN, Sorbonne Université, F-75013 Paris, France." } }, { "@type": "Person", "name": "Maryam Darabi", "url": "https://questionsmedicales.fr/author/Maryam%20Darabi", "affiliation": { "@type": "Organization", "name": "National Institute for Health and Medical Research (INSERM), UMRS 1166 ICAN, Faculty of Medicine Pitié-Salpêtrière, Sorbonne University, Paris, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37852142", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clinsp.2023.100289" } }, { "@type": "ScholarlyArticle", "name": "Association of long noncoding RNA GAS5 gene polymorphism with progression of diabetic kidney disease.", "datePublished": "2024-08-13", "url": "https://questionsmedicales.fr/article/39239549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7150/ijms.99545" } }, { "@type": "ScholarlyArticle", "name": "Whole transcriptome analysis of long noncoding RNA in beryllium sulfate-treated 16HBE cells.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35679967", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.taap.2022.116097" } }, { "@type": "ScholarlyArticle", "name": "A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36490353", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.18632/aging.204426" } }, { "@type": "ScholarlyArticle", "name": "A Long Noncoding RNA Derived from lncRNA-mRNA Networks Modulates Seed Vigor.", "datePublished": "2022-08-22", "url": "https://questionsmedicales.fr/article/36012737", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms23169472" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Lipoprotéines", "item": "https://questionsmedicales.fr/mesh/D008074" }, { "@type": "ListItem", "position": 5, "name": "Lipoprotéines HDL", "item": "https://questionsmedicales.fr/mesh/D008075" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lipoprotéines HDL - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lipoprotéines HDL", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lipoprotéines HDL", "description": "Comment mesurer le taux de HDL ?\nQuel est le taux normal de HDL ?\nQuels tests diagnostiques sont utilisés ?\nComment interpréter un faible taux de HDL ?\nLes lipoprotéines HDL sont-elles mesurables ?", "url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=RNA,+Long+Noncoding&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lipoprotéines HDL", "description": "Quels symptômes indiquent un faible HDL ?\nLe faible HDL cause-t-il des douleurs ?\nY a-t-il des signes cliniques associés ?\nUn HDL bas peut-il affecter l'énergie ?\nLe HDL bas est-il lié à d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=RNA,+Long+Noncoding&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lipoprotéines HDL", "description": "Comment prévenir un faible taux de HDL ?\nLe tabagisme affecte-t-il le HDL ?\nL'alcool influence-t-il le HDL ?\nLe stress impacte-t-il le HDL ?\nLes examens réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=RNA,+Long+Noncoding&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lipoprotéines HDL", "description": "Comment augmenter le taux de HDL ?\nLes médicaments peuvent-ils aider ?\nQuels aliments favorisent le HDL ?\nLe HDL peut-il être traité par des suppléments ?\nLes changements de mode de vie sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=RNA,+Long+Noncoding&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lipoprotéines HDL", "description": "Quelles complications sont liées à un faible HDL ?\nLe HDL bas cause-t-il des AVC ?\nUn faible HDL affecte-t-il la santé mentale ?\nLe HDL bas est-il lié au diabète ?\nLe HDL bas peut-il entraîner des maladies rénales ?", "url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=RNA,+Long+Noncoding&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lipoprotéines HDL", "description": "Quels sont les principaux facteurs de risque pour un faible HDL ?\nL'âge influence-t-il le taux de HDL ?\nLe sexe affecte-t-il le HDL ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le HDL ?", "url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=RNA,+Long+Noncoding&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer le taux de HDL ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le taux de HDL se mesure par une analyse sanguine lipidique." } }, { "@type": "Question", "name": "Quel est le taux normal de HDL ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un taux de HDL supérieur à 1,0 g/L est considéré comme normal chez les hommes." } }, { "@type": "Question", "name": "Quels tests diagnostiques sont utilisés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent le profil lipidique et parfois des tests génétiques." } }, { "@type": "Question", "name": "Comment interpréter un faible taux de HDL ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un faible taux de HDL augmente le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les lipoprotéines HDL sont-elles mesurables ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont mesurables par des tests sanguins spécifiques." } }, { "@type": "Question", "name": "Quels symptômes indiquent un faible HDL ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Un faible HDL est souvent asymptomatique mais peut indiquer un risque accru de maladies cardiaques." } }, { "@type": "Question", "name": "Le faible HDL cause-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, un faible taux de HDL ne cause pas de douleurs directement." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de signes cliniques spécifiques liés uniquement au HDL." } }, { "@type": "Question", "name": "Un HDL bas peut-il affecter l'énergie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un HDL bas n'affecte pas directement les niveaux d'énergie." } }, { "@type": "Question", "name": "Le HDL bas est-il lié à d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un HDL bas est souvent associé à des maladies métaboliques et cardiovasculaires." } }, { "@type": "Question", "name": "Comment prévenir un faible taux de HDL ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie actif et une alimentation équilibrée aide à prévenir un faible HDL." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il le HDL ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme réduit le taux de HDL, augmentant le risque cardiovasculaire." } }, { "@type": "Question", "name": "L'alcool influence-t-il le HDL ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation modérée d'alcool peut augmenter le HDL, mais l'excès est nuisible." } }, { "@type": "Question", "name": "Le stress impacte-t-il le HDL ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut affecter négativement le taux de HDL." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers aident à surveiller le taux de HDL et la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment augmenter le taux de HDL ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier, une alimentation saine et l'arrêt du tabac peuvent augmenter le HDL." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments comme les statines peuvent aider à augmenter le HDL." } }, { "@type": "Question", "name": "Quels aliments favorisent le HDL ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les acides gras oméga-3, les noix et l'huile d'olive favorisent le HDL." } }, { "@type": "Question", "name": "Le HDL peut-il être traité par des suppléments ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments comme les oméga-3 peuvent aider à augmenter le HDL." } }, { "@type": "Question", "name": "Les changements de mode de vie sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements de mode de vie peuvent significativement améliorer le taux de HDL." } }, { "@type": "Question", "name": "Quelles complications sont liées à un faible HDL ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Un faible HDL est associé à un risque accru de maladies cardiaques et d'accidents vasculaires." } }, { "@type": "Question", "name": "Le HDL bas cause-t-il des AVC ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un faible taux de HDL peut augmenter le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Un faible HDL affecte-t-il la santé mentale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre un faible HDL et des troubles de l'humeur." } }, { "@type": "Question", "name": "Le HDL bas est-il lié au diabète ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un faible HDL est souvent observé chez les personnes diabétiques." } }, { "@type": "Question", "name": "Le HDL bas peut-il entraîner des maladies rénales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un faible HDL peut être associé à un risque accru de maladies rénales." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour un faible HDL ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le tabagisme, l'inactivité physique et une mauvaise alimentation sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le taux de HDL ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le taux de HDL tend à diminuer avec l'âge, surtout chez les femmes après la ménopause." } }, { "@type": "Question", "name": "Le sexe affecte-t-il le HDL ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes ont généralement des taux de HDL plus élevés que les hommes." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à un faible taux de HDL." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le HDL ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque de faible HDL." } } ] } ] }

Sources (10000 au total)

An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina.

Stable angina develops during physical activity or stress, and it is typically an aspect of Coronary Heart Disease (CHD) that can lead to arrhythmia, heart failure and even sudden death. ANRIL, an Ant... The authors enrolled 62 patients with myocardial infarction and 59 with stable angina before primary percutaneous coronary intervention, as well as 48 healthy volunteers. Their peripheral blood was co... The data showed that ANRIL is a better diagnostic indicator than cardiac troponin I in patients with stable angina and that the levels of ANRIL are higher in patients with stable angina than those wit... The levels of ANRIL in peripheral plasma could be used as a good biomarker for stable angina....

The association between long noncoding RNA ABHD11-AS1 and malignancy prognosis: a meta-analysis.

Accumulating evidence has highlighted that lncRNA ABHD11-AS1 plays an essential role in tumorigenesis and is expected to become a new predictive biomarker and ideal target for cancer therapy, whereas ... Eight databases were comprehensively screened for relevant articles on January 1, 2024. The significance of ABHD11-AS1 in malignancies was determined by odds ratios (ORs) or hazard ratios (HRs) with c... Fourteen clinical studies comprising eight kinds of malignancies and 1215 malignancy cases were enrolled into this meta-analysis. The pooled results showed that increased ABHD11-AS1 expression was rem... Current evidence supports the association of elevated ABHD11-AS1 expression with poor prognosis. Thereby, ABHD11-AS1 may be considered as a promising biomarker to screen cancer and predict malignancy ...

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia.

Optimized strategies for risk classification are essential to tailor therapy for patients with biologically distinctive disease. Risk classification in pediatric acute myeloid leukemia (pAML) relies o... To identify lncRNA transcripts associated with outcomes, we evaluated the annotated lncRNA landscape by transcript sequencing of 1,298 pediatric and 96 adult AML specimens. Upregulated lncRNAs identif... Training set cases with positive lncScores had 5-year EFS and overall survival rates of 26.7% and 42.7%, respectively, compared with 56.9% and 76.3% with negative lncScores (hazard ratio, 2.48 and 3.1... Inclusion of the lncScore enhances predictive power of traditional cytogenetic and mutation-defined stratification in pAML with potential, as a single assay, to replace these complex stratification sc...